Three-Weekly Doses of Azithromycin for Indigenous Infants Hospitalized with Bronchiolitis: A Multicentre, Randomized, Placebo-Controlled Trial

BACKGROUND: Bronchiolitis is a major health burden in infants globally, particularly among Indigenous populations. It is unknown if 3 weeks of azithromycin improve clinical outcomes beyond the hospitalization period. In an international, double-blind randomized controlled trial, we determined if 3 w...

Descripción completa

Detalles Bibliográficos
Autores principales: McCallum, Gabrielle B., Morris, Peter S., Grimwood, Keith, Maclennan, Carolyn, White, Andrew V., Chatfield, Mark D., Sloots, Theo P., Mackay, Ian M., Smith-Vaughan, Heidi, McKay, Clare C., Versteegh, Lesley A., Jacobsen, Nerida, Mobberley, Charmaine, Byrnes, Catherine A., Chang, Anne B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404864/
https://www.ncbi.nlm.nih.gov/pubmed/25954737
http://dx.doi.org/10.3389/fped.2015.00032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404864/
https://www.ncbi.nlm.nih.gov/pubmed/25954737
http://dx.doi.org/10.3389/fped.2015.00032

Ejemplares similares